Rolf Barth to United States
This is a "connection" page, showing publications Rolf Barth has written about United States.
Connection Strength
0.138
-
The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System. Transplantation. 2023 10 01; 107(10):e247-e256.
Score: 0.023
-
Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States: A Randomized Controlled Trial. Ann Surg. 2023 Nov 01; 278(5):e912-e921.
Score: 0.023
-
Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress. Front Endocrinol (Lausanne). 2021; 12:789526.
Score: 0.020
-
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States. Am J Transplant. 2021 07; 21(7):2620-2622.
Score: 0.019
-
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375.
Score: 0.019
-
Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15. Transplantation. 2020 04; 104(4):762-769.
Score: 0.018
-
Diabetic nephropathy after kidney transplantation in patients with pretransplantation type II diabetes: A retrospective case series study from a high-volume center in the United States. Clin Transplant. 2018 12; 32(12):e13425.
Score: 0.016